GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (STU:6BG) » Definitions » Other Gross PPE

Lytix Biopharma AS (STU:6BG) Other Gross PPE : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS Other Gross PPE?

Lytix Biopharma AS's Other Gross PPE for the quarter that ended in Dec. 2024 was €0.00 Mil.

Lytix Biopharma AS's quarterly Other Gross PPE increased from Jun. 2024 (€0.01 Mil) to Sep. 2024 (€0.24 Mil) but then declined from Sep. 2024 (€0.24 Mil) to Dec. 2024 (€0.00 Mil).

Lytix Biopharma AS's annual Other Gross PPE increased from Dec. 2022 (€-0.00 Mil) to Dec. 2023 (€0.00 Mil) and increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil).


Lytix Biopharma AS Other Gross PPE Historical Data

The historical data trend for Lytix Biopharma AS's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lytix Biopharma AS Other Gross PPE Chart

Lytix Biopharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial - - - - -

Lytix Biopharma AS Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.01 0.24 -

Lytix Biopharma AS Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Lytix Biopharma AS Business Description

Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401, and LTX-315 are in the pipeline.

Lytix Biopharma AS Headlines

No Headlines